+

WO2001052817A3 - Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles - Google Patents

Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles Download PDF

Info

Publication number
WO2001052817A3
WO2001052817A3 PCT/US2001/002299 US0102299W WO0152817A3 WO 2001052817 A3 WO2001052817 A3 WO 2001052817A3 US 0102299 W US0102299 W US 0102299W WO 0152817 A3 WO0152817 A3 WO 0152817A3
Authority
WO
WIPO (PCT)
Prior art keywords
biologically relevant
cochleate
relevant molecules
delivering biologically
cochleates
Prior art date
Application number
PCT/US2001/002299
Other languages
English (en)
Other versions
WO2001052817A2 (fr
Inventor
Leila Zarif
Tuo Jin
Ignacio Segarra
Raphael J Mannino
Original Assignee
Biodelivery Sciences Inc
Univ New Jersey Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/001684 external-priority patent/WO2000042989A2/fr
Application filed by Biodelivery Sciences Inc, Univ New Jersey Med filed Critical Biodelivery Sciences Inc
Priority to CA002397792A priority Critical patent/CA2397792A1/fr
Priority to AU31114/01A priority patent/AU3111401A/en
Priority to EP01903273A priority patent/EP1259224A2/fr
Priority to JP2001552865A priority patent/JP2003529557A/ja
Publication of WO2001052817A2 publication Critical patent/WO2001052817A2/fr
Publication of WO2001052817A3 publication Critical patent/WO2001052817A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

L'invention concerne un procédé de production d'une structure cochléaire de petite taille à base de lipide. Les structures cochléaires sont obtenues à partir de liposomes qui sont mis en suspension dans une solution aqueuse polymère à deux phases, ce qui permet de séparer de manière différentielle les structures à base de molécules polaires par séparation de phases. La solution polymère à deux phases contenant des liposomes, traitée à l'aide de molécules chargées positivement telles que Ca?2+ ou Zn2+¿, forme un précipité de structures cochléaires présentant des dimensions de particules inférieures à un micron. Le procédé peut être utilisé pour produire des structures cochléaires contenant des molécules biologiquement utiles.
PCT/US2001/002299 2000-01-24 2001-01-24 Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles WO2001052817A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002397792A CA2397792A1 (fr) 2000-01-24 2001-01-24 Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles
AU31114/01A AU3111401A (en) 2000-01-24 2001-01-24 New cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
EP01903273A EP1259224A2 (fr) 2000-01-24 2001-01-24 Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles
JP2001552865A JP2003529557A (ja) 2000-01-24 2001-01-24 コクリエート製剤、その調製方法および生物学的関連分子投与のための用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US2000/001684 WO2000042989A2 (fr) 1999-01-22 2000-01-24 Nouvelles formulations de structures cochleaires isolees dans des hydrogels, procede de preparation et utilisation de celles-ci pour administrer des molecules biologiquement utiles
USPCT/US00/01684 2000-01-24
US09/613,840 2000-07-11
US09/613,840 US6592894B1 (en) 1999-01-22 2000-07-11 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules

Publications (2)

Publication Number Publication Date
WO2001052817A2 WO2001052817A2 (fr) 2001-07-26
WO2001052817A3 true WO2001052817A3 (fr) 2002-02-21

Family

ID=26680118

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/002299 WO2001052817A2 (fr) 2000-01-24 2001-01-24 Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles

Country Status (5)

Country Link
EP (1) EP1259224A2 (fr)
JP (1) JP2003529557A (fr)
AU (1) AU3111401A (fr)
CA (1) CA2397792A1 (fr)
WO (1) WO2001052817A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219473A1 (en) * 2002-03-26 2003-11-27 Leila Zarif Cochleates made with purified soy phosphatidylserine
WO2004064805A1 (fr) * 2003-01-15 2004-08-05 Biodelivery Sciences International, Inc. Preparations cochleaires de nutriants fragiles
WO2004091572A2 (fr) 2003-04-09 2004-10-28 Biodelivery Sciences International, Inc. Compositions contenant des structures cochleaires, dirigees contre l'expression de proteines
WO2004091578A2 (fr) * 2003-04-09 2004-10-28 Biodelivery Sciences International, Inc. Procedes de formation de structures cochleaires, structures cochleaires, et procedes d'utilisation
KR101089534B1 (ko) * 2003-10-15 2011-12-05 가부시키가이샤 나노에그 다가 금속 무기염 피복 레티노인산 나노입자의 입경의조정방법 및 당해 조정방법에 의해 얻어진 나노입자
EP1674094A4 (fr) * 2003-10-15 2009-12-09 Nanoegg Res Lab Inc Composition contenant des nanoparticules d'acide retinoique revetues d'un sel inorganique metallique polyvalent
CA2672338C (fr) 2006-12-15 2017-06-06 National Research Council Of Canada Agregats de lipides polaires d'archaea pour administration a des animaux
ES2741282T3 (es) * 2011-05-05 2020-02-10 Matinas Biopharma Nanotechnologies Inc Composiciones de cocleato y métodos de elaboración y uso de las mismas
JP6923206B2 (ja) * 2015-04-22 2021-08-18 マティナス バイオファーマ ナノテクノロジーズ，インコーポレーテッド マイコバクテリア感染症及び肺疾患を治療するための組成物及び方法
AU2016280276A1 (en) * 2015-06-18 2017-12-07 Matinas Biopharma Nanotechnologies, Inc. Compositions and methods for treating inflammatory disease or conditions
US11123295B2 (en) 2016-07-12 2021-09-21 Matinas Biopharma Nanotechnologies, Inc. Encholeated antifungal compounds for central nervous system delivery and treatment of Cryptococcus infections
KR101989789B1 (ko) 2017-11-30 2019-06-18 (주) 에이치엔에이파마켐 포스파티딜세린/음이온계면활성제/염화칼슘을 이용한 코킬레이트

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997030725A1 (fr) * 1996-02-22 1997-08-28 Raphael James Mannino Vecteurs d'apport de structures cochleaires
US5994318A (en) * 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
WO2000042989A2 (fr) * 1999-01-22 2000-07-27 Biodelivery Sciences, Inc. Nouvelles formulations de structures cochleaires isolees dans des hydrogels, procede de preparation et utilisation de celles-ci pour administrer des molecules biologiquement utiles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994318A (en) * 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
WO1997030725A1 (fr) * 1996-02-22 1997-08-28 Raphael James Mannino Vecteurs d'apport de structures cochleaires
WO2000042989A2 (fr) * 1999-01-22 2000-07-27 Biodelivery Sciences, Inc. Nouvelles formulations de structures cochleaires isolees dans des hydrogels, procede de preparation et utilisation de celles-ci pour administrer des molecules biologiquement utiles

Also Published As

Publication number Publication date
WO2001052817A2 (fr) 2001-07-26
EP1259224A2 (fr) 2002-11-27
JP2003529557A (ja) 2003-10-07
CA2397792A1 (fr) 2001-07-26
AU3111401A (en) 2001-07-31

Similar Documents

Publication Publication Date Title
DK1143933T3 (da) Hidtil ukendte hydrogelisolerede cochleat-formuleringer, fremgangsmåde til fremstilling og deres anvendelse ved afgivelse af biologisk relevante molekyler
WO2001052817A3 (fr) Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles
EP4509118A3 (fr) Lipides peg de haute pureté et leurs utilisations
Evans et al. Thermodynamics of solution of nonpolar gases in a fused salt. Hydrophobic bonding behavior in a nonaqueous system
CA2201120A1 (fr) Lipides du type ceramide modifies par polyethylene glycol et leurs utilisations sous forme de liposomes
EP1266959A3 (fr) Anlage und verfahren zur gewinnen von zellen
WO2003037835A3 (fr) Procede d'elimination d'impuretes polarisables contenues dans des hydrocarbures et melanges d'hydrocarbures
TW356476B (en) Scratch-resistant conductive coatings
BR0113477A (pt) Peptìdios de penetração em membranas e usos dos mesmos
CA2243946A1 (fr) Eau electrolytique reductrice et procede de preparation de celle-ci
WO2000009086A3 (fr) Formulation protegee, dans un seul flacon, pour molecules d'acide nucleique, ses procedes de fabrication par melangeage en ligne, produits et procedes associes
SG11201909419XA (en) Hydrogel for cell culture and biomedical applications
Lind et al. Purification of alpha-toxin from Staphylococcus aureus and application to cell permeabilization
WO2002008408A3 (fr) Systemes de vecteurs modulaires
WO2003041682A3 (fr) Compositions a vecteurs lipidiques garantissant une meilleure retention medicamenteuse
EP1550429A4 (fr) Preparations externes pour la peau
EP1663154A4 (fr) Extrait de i mahonia aquifolium /i , procede d'extraction et composition pharmaceutique contenant ledit extrait
Owoseni Surfactants: Fundamental Concepts and Emerging Perspectives
Fadnavis et al. Reverse micellar extraction of antibiotics from aqueous solutions
WO2002094209A3 (fr) Cremes lipoproteiques contenant des filtres uv
Sandodze et al. Effects of hypomagnetic fields on motility of the cilia of ependymal cells in vivo
AU5869499A (en) Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure
MD20040004A (ro) Metodă de tratament al artrozelor deformante
Chavarriga et al. Polynomial inverse integrating factors
MD1951G2 (ro) Metodă de depistare a acidului hialuronic în preparatele biologice

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2397792

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 552865

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 31114/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001903273

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001903273

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001903273

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载